luisenriquereyes | 1 points
Research paper on Lancet.com - The effect of early treatment with Ivermectin... in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trialResearch paper published January 19, 2021:
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30464-8/fulltext
Paper has this interpretation of the research:
Among patients with non-severe COVID-19 and no risk factors for severe disease receiving a single 400 mcg/kg dose of ivermectin within 72 h of fever or cough onset there was no difference in the proportion of PCR positives. There was however a marked reduction of self-reported anosmia/hyposmia, a reduction of cough and a tendency to lower viral loads and lower IgG titers which warrants assessment in larger trials.
This research paper was published on The Lancet, and international weekly general medical journal founded in 1823. On their site this medical journal says: "The Lancet sets extremely high standards. We select only the best research papers for their quality of work and the progression they bring."